Treatment of the cells with 2-aminoethoxydiphenyl borate (2-APB), a pharmacologic inhibitor of TRPM2 (24), led to decreased proliferation in both lines of human breast adenocarcinoma cells (Fig. 2A-b and A-c). The gene discussed is TRPM2; the disease is breast adenocarcinoma.